New bioscare press release

[<rms () computerbytesman com>]

http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_vie
w&newsId=20070703005718&newsLang=en

July 03, 2007 04:10 PM Eastern Daylight Time 
Presence of UK Physicians in London Bomb Plot May Mean a Bioweapon is Next,
According to PharmAthene CEO, David Wright 

ANNAPOLIS, Md.--(BUSINESS WIRE)--The attempted bomb attacks this week in
London allegedly by five doctors foreshadows a more dangerous world,
according to David Wright, CEO of PharmAthene, a leading biodefense company
that develops and commercializes biomedical products to counter chemical and
biological weapons. 

“The presence of so many physicians is very disquieting,” said Wright.
“Given their training in life sciences, it’s not a stretch of the
imagination to believe that they may soon graduate from vehicle bombs to
bioweapons.” 

Five of the eight suspects arrested by British authorities are doctors or
training to become doctors, according to news articles. One suspect, Bilal
Abudulla, earned a medical degree in Baghdad and then moved to Britain where
he worked as a doctor at the Royal Alexandra Hospital. Another suspect,
Mohammed Asha, earned a medical degree in Jordan. He relocated to Britain,
where he was training to be a neurosurgeon. A third doctor appears to have
been from Bangalore, India. 

“Doctors have access not only to the technology and training to build
bioweapons,” said Wright, “but access to laboratory facilities and the
equipment to build them.” 

Al Qaeda has recruited scientists to construct chemical and biological
weapons, including an anthrax weapon. Abdur Rauf, a Pakistani with an
advanced degree in microbiology, reportedly was a member of a prestigious
scientific organization. He traveled throughout Europe to obtain anthrax
spores and equipment for a laboratory in Kandahar to weaponize the spores.
The plot was foiled by authorities. 

“Anthrax represents the most serious biowarfare risk we face today,” said
Wright. “The anthrax attacks on the various media outlets and U.S. Senate in
2001, which killed five people and injured 17 others, demonstrate how real
the treat is.” 

PharmAthene, headquartered in Annapolis, was established in 2001. The
company’s main biomedical products are: 1) Protexia ©, the first drug
developed to protect against chemical weapons; and 2) Valortim ©, a human
antibody to prevent and treat infection caused by inhalation anthrax. 
David Wright has extensive experience in the biotechnology industry. He
previously was President and CEO of GenVec Inc., President and Chief
Business Officer of Guilford Pharmaceuticals, and Executive Vice President
of MedImmune, Inc. 



_______________________________________________
Fun and Misc security discussion for OT posts.
https://linuxbox.org/cgi-bin/mailman/listinfo/funsec
Note: funsec is a public and open mailing list.